1. Pink Sheet
  2. >>Regulatory Trackers
  3. >>US FDA Performance Tracker

Pregnancy Labeling: US FDA Ponders Whether Changes Needed To Overcome Risk Misperceptions

 
• By Sue Sutter

Risk Communication Advisory Committee will opine on impact that Pregnancy and Lactation Labeling Rule has had in conveying safety evidence useful to making prescribing decisions for pregnant patients and whether current labeling language can be improved upon.

Pregnant woman sitting on a bench. on background the children play. warm weather

The US FDA is seeking advisory committee help in deciding whether changes to drug labeling language are needed to better convey the risks of products used during pregnancy.

The agency's Risk Communication Advisory Committee will meet March 5-6 to discuss the effectiveness of communications about risk information on...

More from US FDA Performance Tracker

More from Regulatory Trackers